Renal transplantation in the UK and Republic of Ireland

R J Johnson1, M A Belger, J D Briggs

  • 1UK Transplant, Bristol, United Kingdom.

Clinical Transplants
|August 22, 2001
PubMed

Insights

Donor age is the most critical factor for 5-year renal transplant survival. Increasing donor age significantly raises transplant failure risk, while HLA matching

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Public Health

Background:

  • Renal transplantation is a vital treatment for end-stage renal disease.
  • Factors influencing transplant success require ongoing investigation to optimize patient outcomes.
  • UK transplant data provides a valuable resource for analyzing long-term graft survival.

Purpose of the Study:

  • To identify significant prognostic factors affecting 5-year graft survival in adult cadaveric renal transplantation.
  • To analyze trends in donor and recipient demographics and HLA matching over time.
  • To evaluate the impact of the UK Kidney Allocation Scheme on transplant outcomes.

Main Methods:

  • Analysis of 5-year transplant survival data from 5,963 first grafts and 1,078 regrafts (1990-1997).
  • Statistical analysis of factors including donor age, recipient age, diabetes, HLA matching, and kidney exchange.
  • Examination of transplant outcomes across different time epochs (short-term, medium-term, long-term).

Main Results:

  • Donor age was the most significant prognostic factor; older donors (≥60 years) doubled the risk of graft failure compared to younger donors (18-34 years).
  • The influence of HLA matching on 5-year survival has diminished over time, with no significant difference between 000 and favorably matched transplants in recent years.
  • Recipient age and diabetes impacted outcomes throughout all post-transplant epochs, while kidney exchange between centers affected short-term outcomes.

Conclusions:

  • Donor age is a critical determinant of long-term renal transplant success.
  • Changes in HLA matching significance suggest evolving donor pools or improved immunosuppression.
  • The UK Kidney Allocation Scheme aims to optimize donor-recipient matching, potentially improving outcomes, especially for older recipients and children.

Related Concept Videos

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...